in Cancer Research
The National Cancer Act turns 40, and we
present examples of research accomplishments
by OSUCCC – James investigators
MICHAEL A. CALIGIURI, MD
OFFICER, JAMES CANCER
HOSPITAL AND SOLOVE
THE OHIO STATE
UNIVERSITY, JOHN L.
FOUNDATION CHAIR IN
This Dec. 23rd our nation will
celebrate the 40th anniversary
of the National Cancer Act. The
research done since the act's passage
has led in many cases to cures, to
extraordinary new treatments, to
earlier detection and to improved
quality of life for cancer survivors.
Yet, some 570,000 Americans will
die of cancer this year. This issue of
Frontiers shows some of what we are
doing to reduce that number.
Our cover story offers examples
of progress in clinical and
translational research that is already
making a difference in patients'
lives. Another story looks at how
retroviral research is improving our
understanding of cancer and read
about our skull-base surgery program
for a remarkable example of clinical
innovations that are improving
patients' quality of life.
In this issue's Frontline, Peter
Shields, MD, internationally
and expert in cancer prevention,
presents an insightful perspective
of cancer prevention research. Peter
recently joined Ohio State from
Georgetown University as deputy
director of the OSUCCC – James.
We've successfully worked in
the past to improve clinical-trials access. Recently we took another
step toward improving the clinical
trials process. It is all but impossible
to conduct clinical trials evaluating
combinations of experimental targeted
agents, largely because of intellectual
property, commercialization, profit
and price issues.
In May, the OSUCCC – James
and Friends of Cancer Research
organized a Cancer Drug Development Roundtable to begin
tackling this complex problem.
The Ohio State Roundtable
brought together representatives
of academia, government, the
pharmaceutical industry, legal
services and advocacy groups
to address the barriers to codeveloping
cancer drugs owned by
competing interests. Our goal is to
bring new cancer treatments more
quickly to patients.
Finally, watch for our video
icon. Visit Frontiers online and
click on it to see OSUCCC – James
researchers talking about their work
or their views on progress in cancer research.